Enteric Disease Testing Market to grow with a CAGR of 4.69% through 2029
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Enteric Disease Testing Market during the forecast period 2025-2029
According
to TechSci Research report, “Enteric Disease Testing Market - Global Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2019-2029”, Global Enteric Disease Testing
Market has valued at USD 3.98 billion in 2023 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 4.69% through 2029.
Collaborations and partnerships among leading companies are instrumental in consolidating expertise and bolstering market presence. Increased awareness significantly propels the demand for enteric disease testing. Heightened consciousness about health and wellness prompts individuals to seek medical advice and diagnostic testing upon experiencing symptoms of enteric diseases. The public's growing awareness of food safety issues, including foodborne illnesses, is fueled by high-profile outbreaks and recalls, prompting individuals to advocate for rigorous testing of food products. Media coverage of enteric disease outbreaks, food recalls, and public health campaigns further amplifies awareness, emphasizing the importance of health and safety. Access to information online enables individuals to educate themselves about enteric disease symptoms and risks, fostering a greater understanding of the need for testing when experiencing gastrointestinal symptoms. Healthcare providers, sensitized by awareness campaigns and educational efforts, are more inclined to recommend enteric disease testing when deemed necessary, as patients become increasingly aware of its significance.
Browse
over XX market data Figures and spread through XX Pages and an in-depth TOC on
" Global Enteric Disease Testing Market”
The expense associated with enteric disease testing presents a notable challenge in the global market, impacting various stakeholders including healthcare providers, patients, and public health systems. Testing costs can serve as a deterrent for individuals seeking healthcare services, particularly in regions with limited access to affordable healthcare. Disparities in testing access can result in healthcare inequalities, as those with limited financial means may encounter difficulties in obtaining necessary testing, potentially leading to delays in diagnosis and treatment. Healthcare systems and governments are required to allocate funds for diagnostic testing programs, which can strain budgets and resources, particularly in areas with a high prevalence of enteric diseases. The establishment and maintenance of diagnostic infrastructure, such as clinical laboratories and point-of-care testing facilities, entail significant financial investments. In resource-constrained settings where enteric diseases are prevalent, testing costs pose a substantial barrier to implementing robust diagnostic initiatives, potentially impeding early detection and treatment.
Global Enteric Disease Testing Market is segmented
based on Disease Type, End User, and by region.
Based on end user, the Global Enteric Disease Testing Market largest share was held by Hospitals & Clinics segment in the forecast period and is predicted to continue expanding over the coming years. Hospitals and clinics serve as primary points of access to healthcare services for individuals with enteric disease symptoms. Patients often seek initial diagnosis and treatment at these facilities, which drives the demand for enteric disease testing. Hospitals and clinics offer a wide range of medical services, including diagnostics, treatment, and patient care. This makes them well-suited to provide comprehensive enteric disease testing as part of their broader healthcare offerings. Hospitals are equipped to handle severe cases of enteric diseases that require emergency care. Clinics can also address moderate to severe cases. Testing is vital in these settings to guide treatment decisions. Many hospitals have specialized departments, such as gastroenterology and infectious disease units, that focus on the diagnosis and treatment of enteric diseases. These departments frequently conduct extensive testing to identify specific pathogens causing gastrointestinal issues. Hospitals and clinics typically have experienced medical professionals and access to advanced diagnostic technologies. This expertise ensures accurate and timely diagnosis of enteric diseases. Hospitals provide both inpatient and outpatient care, offering testing services for various patient needs, from routine outpatient screening to more complex inpatient cases.
Based on Region, North America held the largest share in the Global Enteric Disease Testing Market. The well-established private healthcare sector in North America incentivizes investments in diagnostic technologies and enhances access to testing services for individuals with private insurance coverage. Healthcare providers in the region benefit from access to state-of-the-art diagnostic resources, including molecular diagnostics, high-throughput testing, and automated systems. North America's robust capacity for epidemiological surveillance facilitates the prompt identification and containment of enteric disease outbreaks. The insurance and reimbursement frameworks, particularly in the United States, support the utilization of diagnostic tests, simplifying access for patients in need. Intense competition within North America's healthcare landscape drives ongoing innovation and market expansion as companies compete for market share and strive to introduce new and enhanced enteric disease testing solutions.
Some
of the major companies operating in the Global
Enteric Disease Testing Market include:
- Abbott
Laboratories Ltd.
- Beckton
Dickinson & Co.
- Biomerica Inc.
- BIOMÉRIEUX SA
- Bio-Rad
Laboratories, Inc.
- Cepheid
- Coris
BioConcept
- DiaSorin
S.p.A.
- Meridian
Bioscience Inc.
- Quest
Diagnostics Incorporated
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“In the enteric disease testing market,
growth prospects are strong as market players in healthcare, food safety, and
environmental sectors prioritize strategies to prevent, diagnose, and manage
enteric diseases. Sustained investment in research and development, alongside
partnerships among public health agencies, diagnostic manufacturers, and
regulatory authorities, will be crucial to tackle evolving challenges and
fulfill the rising need for precise and prompt enteric disease testing
solutions.," said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based Global management consulting firm.
"Enteric Disease Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases, Rotavirus, Norovirus), End User (Hospitals & Clinics, Diagnostic Centers, Others), by region, and Competition, 2019-2029F" has evaluated the future
growth potential of Global Enteric Disease Testing Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Enteric Disease Testing Market.
Contact
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel:
+13322586602
Email: [email protected]
Website: www.techsciresearch.com